Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Combined epidural-general anesthesia
- Development stage
- Unknown
- Lead developer
- Peking University First Hospital
- Modality
- Small Molecules
- Administration
- Epidural, Intravenous, Inhalation
01
Overview
Combined epidural-general anesthesia (CEGA) is an anesthetic technique that integrates neuraxial (epidural) blockade with systemic general anesthesia. In the context of the clinical research conducted by Peking University First Hospital, this specific regimen involves the administration of ropivacaine and sufentanil via an epidural catheter for intraoperative anesthesia and postoperative analgesia, alongside general anesthesia maintained with propofol and/or sevoflurane. The primary hypothesis behind using CEGA in cancer surgery is that it may attenuate the surgical stress response and preserve immune function, particularly natural killer cell activity, which could potentially reduce the risk of cancer recurrence or metastasis and improve long-term survival in elderly patients with malignant solid tumors.
- Other names
- CEGACombined epidural and general anesthesiaEpidural anesthesia-analgesia plus general anesthesia
02
Targets
NMDAR (Glutamate receptor ionotropic, NMDA)SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)MOR (Mu opioid receptor)GABRA1 (Gamma-aminobutyric acid type A receptor alpha 1 subunit)
Beyond the preview
Go deeper on Combined epidural-general anesthesia.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Combined epidural-general anesthesia.